Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-07-01
2008-07-01
Zeman, Mary K. (Department: 1631)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S005000, C435S006120, C435S007100, C435S069100, C435S320100, C436S501000, C514S04400A, C424S184100
Reexamination Certificate
active
08443345
ABSTRACT:
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome, for expression of polypeptides and use of the polypeptides to prepare antibodies, where both the polypeptides and antibodies may be employed as diagnostic reagents or in therapy, e.g., vaccines and passive immunization. The sequences provide detection of the viral infectious agents associated with the indicated syndromes and can be used for expression of antigenic polypeptides.
REFERENCES:
patent: 4520113 (1985-05-01), Gallo
patent: 4708818 (1987-11-01), Montagnier
patent: 4716102 (1987-12-01), Levy
patent: 443605 (1983-12-01), None
patent: 35 87 394 (1993-06-01), None
patent: 0 020 251 (1980-12-01), None
patent: 0 060 057 (1982-09-01), None
patent: 0 062 574 (1982-10-01), None
patent: 0 073 635 (1983-03-01), None
patent: 0 088 632 (1983-09-01), None
patent: 0 116 201 (1984-08-01), None
patent: 0 136 798 (1985-04-01), None
patent: 0 138 667 (1985-04-01), None
patent: 0 139 216 (1985-05-01), None
patent: 0 152 030 (1985-08-01), None
patent: 0 165 120 (1985-12-01), None
patent: 0 173 529 (1986-03-01), None
patent: 0 178 978 (1986-04-01), None
patent: 0 181 150 (1986-05-01), None
patent: 0 181 150 (1986-05-01), None
patent: 0 185 444 (1986-06-01), None
patent: 0 187 041 (1986-07-01), None
patent: 0 201 540 (1986-11-01), None
patent: 0 178 978 (1992-02-01), None
patent: 2104902 (1983-03-01), None
patent: 84/23659 (1984-09-01), None
patent: 84/16013 (1984-10-01), None
patent: 84/29099 (1984-11-01), None
patent: 85/01473 (1985-01-01), None
patent: 85/04897 (1985-11-01), None
patent: 85/04903 (1985-11-01), None
patent: 86/02383 (1986-04-01), None
patent: 86/06414 (1986-11-01), None
patent: 84/7005 (1984-09-01), None
Manzari et al. 1983 PNAS USA v 80 p. 1574-78, Mar. 1, 1983.
USSN 728,052, Apr. 29, 1985.
USSN 767,303, Aug. 19, 1985.
USSN 685,272, Dec. 24, 1984.
USSN 844,485, Nov. 13, 1986.
Allan et al.,Science(1985) 228:1091-1094.
Amann et al.,Gene(1983) 25:167-178.
Barin et al.,Science(1985) 228:1094-1096.
Beardsley et al.,Nature(1984) 311:195.
Bolivar et al.,Gene(1977) 2:95-113.
Brun-Vezinet et al.,Lancet(1984) 1253-1256.
Casadban et al.,J. Bacteriology(1980) 143(2):971-980.
Chanda et al.,FASEB Proceedings(1985) 44(5):1540.
Chang et al.,J. Cell. Biochem.(1985) 9A: 81 Abstract 0187.
Chang et al.,Science(1985) 228:93-96.
Chang et al.,Nature(1985) 315:151-154.
Chang et al.,Bio/Technology(1985) 3(10):905-909.
Chemical and Engineering News, (1984) p. 7.
Chen et al.,Nature(1984) 309:276-279.
Chen et al.,Nature(1983) 305:502-505.
Chermann et al., in Gottlieb et al. (eds. 1984) “Acquired Immune Deficiency Syndrome”UCLA Symposia on Molecular Biology, News Series, vol. 16 (1984) pp. 31-46.
Clinica,Abstract(1984) p. 9.
De Boer et al.,Proc. Natl. Acad. Sci.(1983) 80:21-25.
DiMaio et al.,Proc. Natl. Acad. Sci.(1982) 79:4030-4032.
Dina et al.,DNA(1985) 4(1):56.
Ellrodt et al.,Lancet(1984) 1:1383-1385.
Fisher et al.,Nature(1985) 316:262-265.
Fischinger et al.,Cancer Research(1985) 45:4694s-4699s.
French, T.J.,First Declaration of T.J. French(1994).
Gallo et al., in Gottlieb et al. Eds. (1984) pp. 47-58 “Acquired Immune Deficiency Syndrome”UCLA Symposia on Molecular Biology, New Series(1984) 16:47-58.
Gluzman et al.,Cell(1981) 23:175-182.
Gnann et al.,J. Virology(1987) 61(8):2639-2641.
Gray et al.,Proc. Natl. Acad. Sci.(1982) 79:6598-6602.
Groopman et al.,New Eng. J. Med.(1984) 311(22) :1419-1422.
Hahn et al.,Nature(1984) 312:166-169.
Hattori et al.,Virology(1984) 136:338-347.
Huang et al.,DNA(1985) 4(1):70.
Karn et al.,Meth. Enzymology(1983) 101:3-19.
Kitchen et al.,Nature(1984) 312:367-369.
Kiyokawa et al.,Proc. Natl. Acad. Sci.(1984) 81:6202-6206.
Levy et al.,Ann. Int. Med.(1985) 103:694-699.
Liou et al.,DNA(1985) 4(1):71.
Luciw et al.,DNA(1985) 4(1):71.
Maniatis et al.,Cold Spring Harbor Laboratory“Molecular Cloning” (1982) pp. 406-427.
Maxam et al.,Methods Enzymol.(1980) 65:499-560.
Mellon et al.,Cell(1981) 27:279-288.
Montagnier et al.,Ann. Virol.(1984) 135E:119-134.
Montagnier et al.,Virology(1985) 144:283-289.
Montagnier et al., in Retroviruses in Human Lymphoma/Leukemia (1985) (Miwa et al. Eds)Proceedings of the 15th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo (1984) (1985) pp. 319-331.
Muesing et al.,Nature(1985) 313:450-458.
Mulligan et al.,Mol. Cell. Biol. 1(5):449-459.
New York Times (National Edition), (1984) p. E91.
New York Times (National Edition), (1984) p. 11.
New York Times (National Edition), (1984) p. 16.
Oroszlan et al.,PNAS(1982) 79:1291-1294.
Ramsay et al.,Lancet(1984) pp. 397-398.
Ratner et al.,Nature(1985) 313:277-284.
Robey et al,Science(1985) 228:593-595.
Ruther et al.,EMBO Journ.(1983) 2:1791-1794.
Sanchez-Pescador et al.,AIDS, Papers from Sci.(1985) 410-428.
San Fransisco Chronicle, front and back pages (Oct. 9, 1984).
Sanger et al.,PNAS(1977) 74:5463-5467.
Sarver et al.,Proc. Natl. Acad. Sci., (1982) 79:7147-7151.
Sarver et al.,Mol. Cell. Biol.(1981) 1:486-496.
Schupbach et al.,Science(1984) 224:607-610.
Schupbach et al.,Science(1984) 224:503-506.
Seiki et al.,PNAS(1982) 79:6899-6902.
Seiki et al.,PNAS(1983) 80:3618-3622.
Shatzman et al., inExperimental Manipulation of Gene Expression(Inouye ed.) (1983) pp. 1-14.
Shimitake et al.,Nature(1981) 292:128-132.
Stanley et al.,EMBO Journ.(1984) 3:1429-1434.
Starcich et al.,Cell(1986) 45:637-648.
Towbin et al.,Proc. Natl. Acad. Sci.(1979) 76:4350-4354.
Wain-Hobson et al.Cell(1985) 40:9-17.
Weinstock et al.,Proc. Natl. Acad. Sci.(1983) 80:4432-4436.
Winnacker et al.,Gene and Klone(1984).
Wong-Staal et al.,Nature(1985) 317:395-403.
Cohen et al.,J. Hyg., Cambridge, (1984) 93:225-232.
Roggendorf et al.,J. Viroglical Methods, (1983) 6:61-70.
Peutherer et al.,Med. Laboratory Sciences, (1981) 38:355-358.
Alizon et al.,Nature, (1984) 312:757-760.
Arya, et al.,Science, (1984) 225:927-930.
Barre-Sinoussi, et al.,Science, (1983) 220:868-871.
Chang, et al.,Nature, (1985) 315:151-154.
Crowl, R., et al.,Cell(1985) 41:979-986.
Culliton,AIDS: Papers from Science, (1982-1985) 266-277.
Fauci, et al.,Annals of Internal Medicine, (1984) 100:92-106.
Fenyo, et al.,AIDS 3(Suppl. 1):S5-S12 (1989).
Feorino, et al.,Science, (1984) 225:69-72.
Gallo, et al.,Science, (1984) 224:500.
Gallo, et al.,Science, (1984) 224:497-504.
Gurgo, et al.,Virology, 164:531-536.
Ho, et al.,Science, (1984) 226:451-453.
Kalyanaraman, et al.,Science, (1984) 224:321-323.
Klatzmann, et al.,Science, (1984) 225:59-62.
Klatzmann, et al.,Nature, (1984) 312:767-768.
Lee, et al.,Science(1984) 226:57-61.
Levy, et al.,Science(1984) 225:840-842.
Looney, et al.,Science(1988) 241:357-359.
Luciw, et al.,Nature(1984) 312:760-763.
Marx,Science, (1984) 224:475-477.
Melbye, et al.,British Medical Journal(1984) 289:573-575.
Meyerhans, A., et al.,Cell(1989) 58:901-910.
Montagnier, et al.,New Retrovirus in LAS and AIDS(1984).
Montagnier, et al.,Science(1984) 225:63-66.
Popovic, et al.,Science(1984) 224:497-500.
Samuel, et al.,Science(1984) 226:1094-1097.
Sanchez-Pescador, et al.,Science(1985) 227:484-492.
Safai, et al.,Lancet(1984) 1438-1440.
Sarngadharan, et al.,Science(1984) 224:506-508.
Saxinger, et al.,Laboratory Investigation(1983) 49:371-377.
Schupback, et al.,Science(1984) 224:607-609.
Shaw, et al.,Science(1984) 226:1165-1171.
Shaw, et al.,AIDS: Papers from Science, (1982-1985) 356-268.
Sinkovics, e al.,Reviews of Infectious Diseases(1984) 6:745-760.
Vilmer, et al.,Lancet(1984) 1:753.
Wain-Hobson, S.,AIDS 3(Suppl. 1):S13-S18 (1989).
Expert Report of John A. T. Young, Ph.D.
Expert Report of B. Matija Peterlin, M.D.
Expert Report of Robin A. Weiss, Ph.D.
Amended Expert Report of Hans-Martin Jack, Ph.D.
Expert Report of Herman N. Eisen, Ph.D.
Original Notice of Opposition by Abbott Laboratories filed Jun. 11, 1993.
Supplemental version of original Notice of Opposition by Abbott filed Mar. 9, 1994.
Notice of Opposition (plus English translation) by Biotest AG filed Mar. 3, 1994.
Notice of Opposition (plus English translati
Barr Philip J.
Dina Dino
George-Nascimento Carlos
Hallewell Rob
Luciw Paul A.
Harbin Alisa A.
Hemmendinger Lisa
Novartis Vaccines and Diagnostics Inc.
Zeman Mary K.
LandOfFree
Human immunodeficiency virus (HIV) nucleotide sequences does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human immunodeficiency virus (HIV) nucleotide sequences, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human immunodeficiency virus (HIV) nucleotide sequences will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3927650